var data={"title":"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/contributors\" class=\"contributor contributor_credentials\">Deborah P Merke, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/contributors\" class=\"contributor contributor_credentials\">Lynnette K Nieman, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/contributors\" class=\"contributor contributor_credentials\">Benjamin A Raby, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/contributors\" class=\"contributor contributor_credentials\">Kathryn A Martin, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 29, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Defective conversion of 17-hydroxyprogesterone to 11-deoxycortisol accounts for more than 90 percent of cases of congenital adrenal hyperplasia (CAH) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1-3\" class=\"abstract_t\">1-3</a>]. This conversion is mediated by 21-hydroxylase, the enzyme encoded by the <em>CYP21A2</em> gene.</p><p>Patients with &quot;classic&quot; or the most severe form of CAH due to 21-hydroxylase deficiency (21OHD) present during the neonatal period and early infancy with adrenal insufficiency with or without salt-losing, or as toddlers with virilization. Females have genital ambiguity.</p><p>&quot;Nonclassic,&quot; or late-onset 21OHD, presents later in life with signs of androgen excess and without neonatal genital ambiguity. Clinical features in childhood may include premature pubarche and accelerated bone age; adolescent and adult females may present with hirsutism, menstrual irregularity, infertility, and acne. Some patients with nonclassic CAH remain asymptomatic.</p><p>The pathophysiology, genetics, and clinical manifestations of CAH due to <em>CYP21A2</em> mutations will be reviewed here. The diagnosis and treatment of classic 21OHD in adults and in children and an overview of nonclassic and unusual CAHs are discussed elsewhere. (See <a href=\"topic.htm?path=diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">&quot;Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;</a> and <a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-adults\" class=\"medical medical_review\">&quot;Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">&quot;Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;</a> and <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-nonclassic-late-onset-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a> and <a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias\" class=\"medical medical_review\">&quot;Uncommon congenital adrenal hyperplasias&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PREVALENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common cause of congenital adrenal hyperplasia (CAH) worldwide, accounting for &gt;90 percent of cases, is 21-hydroxylase deficiency (21OHD) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1\" class=\"abstract_t\">1</a>]. Based upon neonatal screening studies that detect classic CAH, 21OHD is one of the more common inherited disorders. Data from approximately 6.5 million newborn infants screened worldwide show an estimate of approximately 1 in 15,000 livebirths [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/4,5\" class=\"abstract_t\">4,5</a>]. Prevalence varies according to ethnicity and geographic area. This number varies from as low as 1 in 28,000 in the Chinese population [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/6\" class=\"abstract_t\">6</a>], to 1 in 5000 to 23,000 live births in Caucasian [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/7,8\" class=\"abstract_t\">7,8</a>], to as high as 1 in 280 in Yupik Eskimos in Alaska [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/9\" class=\"abstract_t\">9</a>] and 1 in 2100 in the French island of La Reunion [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/5\" class=\"abstract_t\">5</a>].</p><p>In the United States, the prevalence is lower in African Americans than in Caucasians (1 in 42,000 versus 1 in 15,500, respectively) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/10\" class=\"abstract_t\">10</a>].</p><p>Approximately 67 percent of classic patients are classified as &quot;salt-losing,&quot; while 33 percent of classic patients have &quot;non-salt-losing&quot; or the &quot;simple virilizing&quot; form, reflecting the degree of aldosterone deficiency [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/4\" class=\"abstract_t\">4</a>].</p><p>The nonclassic form is one of the most common autosomal recessive diseases, and the frequency is ethnic specific. Among Caucasians, the prevalence of these forms of the disorder may be as high as 1 in 1000 to 1 in 100 [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/9-11\" class=\"abstract_t\">9-11</a>], with the prevalence being even higher among Mediterraneans, Hispanics, Yugoslavs, and Eastern European Jews [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1\" class=\"abstract_t\">1</a>]. Most patients with the nonclassic form will not be identified by standard screening studies, because they are based upon detection of very high levels of 17-hydroxyprogesterone [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/12\" class=\"abstract_t\">12</a>]. The frequency of heterozygote carriers has been reported to be approximately 1 in 60 to 80 in some studies [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/6,9\" class=\"abstract_t\">6,9</a>] but closer to 1 in 10 in another study using mutation analysis in a European population [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/13\" class=\"abstract_t\">13</a>]. (See <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-nonclassic-late-onset-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The defective conversion of 17-hydroxyprogesterone to 11-deoxycortisol in patients with 21-hydroxylase deficiency (21OHD) results in decreased cortisol synthesis and therefore increased corticotropin (ACTH) secretion (<a href=\"image.htm?imageKey=ENDO%2F81907\" class=\"graphic graphic_figure graphicRef81907 \">figure 1</a>). The resulting adrenal stimulation leads to increased production of androgens. The severity of disease relates to the degree to which the mutations compromise enzyme activity [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/14\" class=\"abstract_t\">14</a>]. (See <a href=\"topic.htm?path=adrenal-steroid-biosynthesis\" class=\"medical medical_review\">&quot;Adrenal steroid biosynthesis&quot;</a> and <a href=\"#H5\" class=\"local\">'Genotype versus phenotype'</a> below.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">GENETICS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As with the other forms of congenital adrenal hyperplasia (CAH), 21-hydroxylase deficiency (21OHD) is transmitted as an autosomal recessive disorder. There may be a survival advantage for heterozygote carriers who have a small, but significantly greater, adrenal response to corticotropin (ACTH) than normal subjects [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/15\" class=\"abstract_t\">15</a>].</p><p>Humans have two <em>CYP21A</em> genes, a nonfunctional pseudogene (<em>CYP21A1</em> or <em>CYP21P</em>) and the active gene (<em>CYP21A2</em> or <em>CYP21</em>), both located in a 35-kilobase region of chromosome 6p21.3 within the major histocompatibility locus&nbsp;[<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/16-19\" class=\"abstract_t\">16-19</a>]. The pseudogene produces a truncated enzyme with no activity because it lacks eight bases from codons 110-112, resulting in a stop codon [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/18,19\" class=\"abstract_t\">18,19</a>].</p><p>The two <em>CYP21A</em> genes are more than 90 percent homologous. This high degree of homology facilitates recombination events during meiosis, with consequent exchanges of segments of DNA between the two genes.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Unequal crossover exchanges leading to deletions of large segments of the <em>CYP21P</em> gene or a nonfunctioning <em>CYP21P</em><span class=\"nowrap\">/<em>CYP21</em></span> fusion gene (macroconversion) account for approximately 20 percent of <em>CYP21A2</em> mutations described to date [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1,7,20\" class=\"abstract_t\">1,7,20</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other hybrid <em>CYP21A1</em><span class=\"nowrap\">/<em>CYP21A2</em></span> gene products have decreased, not absent, enzyme activity. A patient who is heterozygous for this and a typical large gene deletion may have nonclassic 21OHD [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/21\" class=\"abstract_t\">21</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Altered regions of the <em>CYP21A1</em> gene can be transferred to the <em>CYP21A2</em> gene though nonreciprocal gene conversion. This is a process by which a segment of genetic material is transferred to a closely related gene, altering its sequence [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/22,23\" class=\"abstract_t\">22,23</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>These microconversion events represent acquisition of smaller segments of the <em>CYP21A1</em> sequence by the <em>CYP21A2</em> gene and result in deleterious point mutations that reduce enzyme activity [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/3,18-20\" class=\"abstract_t\">3,18-20</a>]. They are present in approximately 70 percent of patients with defined genetic abnormalities.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eighteen such gene conversion mutations account for nearly all affected alleles in various ethnic groups [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/3,24-26\" class=\"abstract_t\">3,24-26</a>]. The remaining 5 percent of patients with defined abnormalities have one or more of the 60 point mutations thus far identified, most being compound heterozygotes [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/3,26-31\" class=\"abstract_t\">3,26-31</a>].</p><p/><p>Among 130 Brazilian patients, 20 percent did not have a known mutation, suggesting that other mutations occur. A novel missense mutation was subsequently identified in three patients with suggestion of a founder effect [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/26\" class=\"abstract_t\">26</a>]. No mutation was detected in the entire coding region of the gene and up to 1 kb of the 5'-flanking promoter region of the gene in one Mexican and three Japanese patients, suggesting that more distant mutations may occur [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/32,33\" class=\"abstract_t\">32,33</a>]. In a second series of 182 unrelated patients with 21OHD, targeted CP21A2 mutation analysis failed to identify mutations in 19 patients (10.4 percent) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/34\" class=\"abstract_t\">34</a>]. On more extensive analysis, novel mutations and previously reported rare mutations were identified in 18 of the 19 subjects: nine previously reported mutations were identified in 12 probands and six novel mutations were identified in six probands (eg, 15 mutations in 18 patients).</p><p>Genotypically, women with the nonclassic form may be either compound heterozygotes (with a classic mutation and a variant allele) or homozygous with two variant alleles. Relatives of women with this attenuated form may have similar biochemical abnormalities, but no signs of androgen excess. Women who carry the classic (severe) mutation have an increased risk of giving birth to a child with classic CAH. (See <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-nonclassic-late-onset-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Genotype versus phenotype</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is not always possible to predict the phenotype of these patients from the specific mutation(s) of the <em>CYP21A2</em> gene, but there are general correlations between genotype and phenotype [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/3,11,27-30,35-42\" class=\"abstract_t\">3,11,27-30,35-42</a>]. Patients with <em>CYP21A2</em> mutations can be divided into groups according to the predicted effect of the mutation on 21-hydroxylase enzymatic activity, as determined by site-directed mutagenesis and expression and in vitro analysis of enzymatic activity [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/27\" class=\"abstract_t\">27</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The salt-losing form of the disorder is most often associated with large deletions or intron 2 mutations that affect splicing and result in no enzyme activity.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with simple virilizing form have low but detectable enzyme activity (ie, 1 to 2 percent) that supports sufficient aldosterone and glucocorticoid production. This most commonly results from point mutations leading to nonconservative amino acid substitutions such as Ile172Asp.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women with the nonclassic form may be either compound heterozygotes (with a classic mutation and a variant allele) or heterozygotes with two variant alleles, allowing for 20 to 60 percent of normal enzymatic activity (eg, with point mutations leading to conservative amino acid substitutions such as Val281Leu).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients who are compound heterozygotes for two different <em>CYP21A2</em> mutations usually have the phenotype associated with the less severe of the two genetic defects [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/24\" class=\"abstract_t\">24</a>]. Heterozygotes may have mild biochemical abnormalities [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/15,43,44\" class=\"abstract_t\">15,43,44</a>], but no clinically important endocrine disorder.</p><p/><p>Despite these general correlations, the <em>CYP21A2</em> mutation phenotype does not always correlate precisely with the genotype [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/8,29,30\" class=\"abstract_t\">8,29,30</a>], suggesting that other genes influence the clinical manifestations. In general, there appear to be high concordance rates between genotype and phenotype in patients with the most severe and the mildest forms of the disease, but less genotype-phenotype correlation in moderately affected patients [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/27,28,39,40\" class=\"abstract_t\">27,28,39,40</a>].</p><p>The utility of genotype in the management of the disease is unknown, and it is not routinely recommended. Genotyping is indicated if the diagnosis remains equivocal following hormonal evaluation or for genetic counseling especially in those seeking fertility [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children#H64509828\" class=\"medical medical_review\">&quot;Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;, section on 'Role of genetic testing'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">CLINICAL PRESENTATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical spectrum of disease ranges from the most severe to mild forms, depending on the degree of 21-hydroxylase deficiency (21OHD). Three main clinical phenotypes have been described: classic salt-losing, classic non-salt-losing (simple virilizing), and nonclassic (late onset):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Females with the classic form (salt-losing and non-salt-losing) present with genital ambiguity. (See <a href=\"topic.htm?path=evaluation-of-the-infant-with-atypical-genitalia-disorder-of-sex-development\" class=\"medical medical_review\">&quot;Evaluation of the infant with atypical genitalia (disorder of sex development)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Males with the salt-losing form who are not identified by neonatal screening present with failure to thrive, dehydration, hyponatremia, and hyperkalemia typically at 7 to 14 days of life.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Males with the classic non-salt-losing form who are not identified by neonatal screening typically present at two to four years of age with early virilization (pubic hair, growth spurt, adult body odor).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonclassic or late-onset 21OHD may present as hirsutism and menstrual irregularity in young women, early pubarche or sexual precocity in school-age children, or there may be no symptoms. (See <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-nonclassic-late-onset-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Infants/children</span></p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Atypical genitalia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Female infants with classic 21OHD are born with atypical genitalia. Female newborns have clitoral enlargement (<a href=\"image.htm?imageKey=PEDS%2F64870\" class=\"graphic graphic_picture graphicRef64870 \">picture 1</a>), labial fusion, and formation of a urogenital sinus caused by the effects of androgen excess on development of the external genitalia in utero. Rarely, genital ambiguity may be so profound that inappropriate sex assignment is made at birth. (See <a href=\"topic.htm?path=evaluation-of-the-infant-with-atypical-genitalia-disorder-of-sex-development\" class=\"medical medical_review\">&quot;Evaluation of the infant with atypical genitalia (disorder of sex development)&quot;</a>.)</p><p>Affected males are normal appearing at birth but may have subtle findings such as hyperpigmentation of the scrotum or an enlarged phallus.</p><p>The surgical management of children born with atypical genitalia is complex. Surgery should be done only in medical centers with substantial experience, and management ideally should be done by a multidisciplinary team that includes specialists in pediatric endocrinology, pediatric surgery, urology, psychosocial services, and genetics [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/46\" class=\"abstract_t\">46</a>]. This topic is discussed in detail separately. (See <a href=\"topic.htm?path=management-of-the-infant-with-atypical-genitalia-disorder-of-sex-development#H492151130\" class=\"medical medical_review\">&quot;Management of the infant with atypical genitalia (disorder of sex development)&quot;, section on 'Overview of decisions about surgery'</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Growth</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with congenital adrenal hyperplasia (CAH) are at risk for early puberty and adult short stature. Exposure to high levels of sex hormones can induce early puberty and premature epiphyseal closure. Excess glucocorticoid exposure secondary to treatment may also suppress growth and contribute to adult short stature.</p><p>Retrospective studies have shown that the final height of treated patients is independent of the degree of control of adrenal androgen concentrations, suggesting that both hyperandrogenism and hypercortisolism play a role in the observed short stature. A meta-analysis of data from 18 centers showed that the mean adult height of patients with classic CAH was 1.4 standard deviations (10 cm) below the population mean [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/47\" class=\"abstract_t\">47</a>]. Patients with nonclassic CAH have a more favorable height prognosis but are also at risk for loss of adult height. (See <a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children#H15\" class=\"medical medical_review\">&quot;Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;, section on 'Growth'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Sexual behavior</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Studies of female patients with classic CAH suggest that exposure to excess androgens during prenatal development may influence the brain as evidenced by the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Female patients with classic CAH have more male-typical childhood play than unaffected girls [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/48,49\" class=\"abstract_t\">48,49</a>] and have more interest in male-typical activities and careers [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/50\" class=\"abstract_t\">50</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one report, 31 women with CAH (mean age 25 years) recalled more cross-gender role behavior and fewer sexual experiences with men than 15 unaffected relatives of the same age [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/51\" class=\"abstract_t\">51</a>]. In contrast, there was no difference in the relationship status between the two groups (eg, <span class=\"nowrap\">married/cohabitating</span> versus single).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adolescent and adult women with CAH may have greater aggressive tendencies than unaffected healthy women [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/52,53\" class=\"abstract_t\">52,53</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Overall, patients with CAH have favorable quality of life [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/54\" class=\"abstract_t\">54</a>] and good psychological health [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/55\" class=\"abstract_t\">55</a>].</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Cognitive function</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The effect of 21OHD on cognitive function is uncertain. Some studies suggest that patients with the most severe form of 21OHD and those who have experienced salt-losing adrenal crises with abnormal electrolytes <span class=\"nowrap\">and/or</span> hypoglycemia as neonates are at risk for cognitive impairment [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/56\" class=\"abstract_t\">56</a>]. This was illustrated in a study of 35 Danish women with CAH and healthy age-matched controls undergoing testing with the Wechsler Adult Intelligence Scale (WAIS) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/57\" class=\"abstract_t\">57</a>]. Women with CAH had significantly lower intelligence quotients (IQs) compared with controls (mean full-scale IQ 84.5 versus 99.1 and mean performance IQ 85.7 versus 101.3 in the CAH and control women, respectively). The salt-losing group had the lowest IQ scores.</p><p>Surprisingly, an IQ advantage has also been reported in a number of studies of CAH [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/58\" class=\"abstract_t\">58</a>], possibly due to socioeconomic, genetic, or hormonal factors.</p><p>Some data have suggested that girls with CAH develop a more male-typical cognitive pattern (better performance on spatial tasks, worse performance on verbal tasks) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/59,60\" class=\"abstract_t\">59,60</a>]. However, in a study of 24 women with salt-losing or simple virilizing 21OHD undergoing detailed cognitive testing, there were no differences in overall IQ, visuospatial processing, or verbal learning and memory, suggesting that prenatal androgen exposure does not have an organizing effect on female cognition [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/61\" class=\"abstract_t\">61</a>].</p><p>Conversely, 54 patients with CAH underwent a virtual water maze test that measures spatial cognition and has established performance sex-differences in healthy controls. Females with the most severe salt-wasting form of CAH and patients with advanced bone age during childhood displayed improved performance, similar to healthy males, suggesting that both in utero and long-term childhood exposure to excess testosterone has long-lasting effects on cognitive function [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/62\" class=\"abstract_t\">62</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Female reproduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fertility rates in women with classic forms of 21OHD are low [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/63\" class=\"abstract_t\">63</a>]. Possible contributing factors include [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/64\" class=\"abstract_t\">64</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperandrogenemia due to inadequate glucocorticoid therapy, thereby resulting in anovulatory cycles [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/63-67\" class=\"abstract_t\">63-67</a>]. The androgen excess is not simply due to corticotropin (ACTH) hypersecretion; other factors include mild hyperresponsiveness of ACTH to corticotropin-releasing hormone stimulation, reduced catalytic activity of the 21-hydroxylase enzyme, and abnormal gonadotropin dynamics with excess ovarian production of progesterone, 17-hydroxyprogesterone, and androgens [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/68\" class=\"abstract_t\">68</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Structural factors related to genital malformations or suboptimal surgical reconstruction may leave the vaginal introitus inadequate and may contribute to impaired reproductive self-image [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/69\" class=\"abstract_t\">69</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fertility rates are related to the severity of the mutation [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/70\" class=\"abstract_t\">70</a>]. Pregnancy rates of 60 to 80 percent and 7 to 60 percent of women have been reported in women with classic non-salt-losing and classic salt-losing CAH, respectively [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/63,67\" class=\"abstract_t\">63,67</a>].</p><p/><p>In women with classic 21OHD who do conceive, their unaffected female offspring do not have genital virilization, but careful management with monitoring of androgen levels during gestation is indicated [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/71\" class=\"abstract_t\">71</a>].</p><p>Adrenal rest tumors in the ovary are rare [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/72\" class=\"abstract_t\">72</a>], unlike in male patients, who often have testicular adrenal rest tumors (see <a href=\"#H14\" class=\"local\">'Testicular adrenal rests'</a> below). In addition to the ovary, adrenal rest tumors have been found in the <span class=\"nowrap\">paraovarian/adnexal</span> area. The tumors are difficult to identify by imaging, and most have been identified during surgery or at autopsy. Imaging with 18F-fluorodeoxyglucose-positron emission <span class=\"nowrap\">tomography/computed</span> tomography <span class=\"nowrap\">(18FDG-PET/CT)</span> localized rest tissue in three women [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/73-75\" class=\"abstract_t\">73-75</a>] (including one with Nelson syndrome); in one case, tumors were only visible after administration of cosyntropin [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/74\" class=\"abstract_t\">74</a>]. The etiology appears related to sustained elevations in ACTH.</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Male reproduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Reproductive function may be impaired in men with 21OHD. Affected boys or young men may have no symptoms or signs of androgen excess. However, they may have testicular masses composed of adrenal tissue.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Testicular adrenal rests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Testicular adrenal rest tumors, which are testicular masses composed of adrenal-like tissue, are common in male patients with 21OHD [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/76-78\" class=\"abstract_t\">76-78</a>].</p><p>Confirmation that these tumors resemble adrenal tissue comes from a study of eight adult patients who underwent testis-sparing surgery [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/79\" class=\"abstract_t\">79</a>]. Adrenal-specific steroid secretion was documented with preoperative spermatic vein sampling, and expression of adrenal-specific enzymes and ACTH receptors was confirmed in tumor tissue.</p><p>The clinical features of testicular rest tumors include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>They are usually diagnosed between the ages of 10 and 20 years but may be found as early as age five [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/80-82\" class=\"abstract_t\">80-82</a>]. In one report of 34 boys with classic 21OHD between the ages of 2 and 18 years who were undergoing testicular ultrasonography, eight (24 percent) were diagnosed with testicular adrenal rests; two of the boys were age seven [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/82\" class=\"abstract_t\">82</a>]. A similar prevalence was reported in a second report of 19 boys (mean age 5.6 years, range 2 to 10 years) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/83\" class=\"abstract_t\">83</a>]. Inhibin B and anti-m&uuml;llerian hormone concentrations were lower in patients compared with age-matched controls, suggesting that gonadal dysfunction was also present.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ultrasound studies suggest that the majority of adolescent and adult males with 21OHD have testicular adrenal rests (18 of 21 [86 percent] and 16 of 17 [94 percent] in two reports) [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/77,78,84\" class=\"abstract_t\">77,78,84</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>They are more common in patients with the salt-losing form than the simple virilizing form, as the former tend to have poorer control and higher ACTH concentrations [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/85\" class=\"abstract_t\">85</a>]. However, a correlation between ACTH levels and tumor growth is not always seen [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/76,77\" class=\"abstract_t\">76,77</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>They are typically bilateral and vary in size from 2 to 40 mm in diameter [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/78\" class=\"abstract_t\">78</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>They may lead to obstruction of seminiferous tubules, gonadal dysfunction, and infertility. (See <a href=\"#H15\" class=\"local\">'Infertility'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some, but not all, regress during glucocorticoid therapy [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/86,87\" class=\"abstract_t\">86,87</a>]. A minority of patients with large adrenal rest tumors eventually requires surgery for pain relief. (See <a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-adults#H3092800708\" class=\"medical medical_review\">&quot;Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults&quot;, section on 'Testicular adrenal rest tumors'</a>.)</p><p/><p>Because of the high prevalence of testicular adrenal rests and their association with infertility in male patients with 21OHD, we suggest screening testicular ultrasonography in adolescence or early adulthood [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/78\" class=\"abstract_t\">78</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Infertility</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most men with 21OHD are fertile as adults, but others have evidence of Leydig cell failure or impaired spermatogenesis [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/77,78,88\" class=\"abstract_t\">77,78,88</a>]. As noted above, testicular adrenal rests may be associated with seminiferous tubule obstruction, gonadal dysfunction, and infertility. (See <a href=\"#H14\" class=\"local\">'Testicular adrenal rests'</a> above.)</p><p>In one study of 17 adolescent and adult men, serum testosterone concentrations were low in six, and seven had abnormal semen analyses [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/77\" class=\"abstract_t\">77</a>]. In a second report of 30 men, those with adrenal rests in the testes were more likely to be infertile [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/76\" class=\"abstract_t\">76</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Epinephrine deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adrenomedullary function is compromised in patients with classic CAH, as illustrated in a study of 38 children with classic 21OHD. Plasma epinephrine and metanephrine concentrations and urinary epinephrine excretion were 40 to 80 percent lower than in normal subjects [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/89\" class=\"abstract_t\">89</a>]. In three patients who underwent bilateral adrenalectomy, the adrenal medulla was poorly formed and the cells contained few vesicles.</p><p>In a second study, the epinephrine response to exercise was significantly reduced in patients with classic 21OHD compared with healthy volunteers [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/90\" class=\"abstract_t\">90</a>], and stress doses of <a href=\"topic.htm?path=hydrocortisone-drug-information\" class=\"drug drug_general\">hydrocortisone</a> did not improve the response [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/91\" class=\"abstract_t\">91</a>]. Thus, 21OHD compromises both the development and subsequent functioning of the adrenomedullary system in severely affected cases. The combination of cortisol deficiency and epinephrine deficiency puts patients at risk for hypoglycemia with illness or prolonged fasting [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/90\" class=\"abstract_t\">90</a>]. Adrenomedullary function has not been studied in patients with nonclassic CAH.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Other findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other clinical findings that have been described include adrenal incidentalomas, pituitary adenomas, insulin resistance, and hyperleptinemia.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although 60 percent of patients with unilateral adrenal incidentalomas and even more of those with bilateral incidentalomas, have exaggerated serum 17-hydroxyprogesterone responses to ACTH stimulation [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1\" class=\"abstract_t\">1</a>], the prevalence of germline <em>CYP21A2</em> mutations is low. However, unilateral and bilateral adrenal incidentalomas were found in 10 of 12 patients with simple virilizing and five of seven patients with late-onset CAH, as well as 9 of 10 heterozygotic siblings [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/92\" class=\"abstract_t\">92</a>]. Most tumors had a diameter of less than 2 cm, but three patients had masses more than 5 cm in size. Adrenal masses in children with <em>CYP21A2</em> deficiency are usually benign [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pituitary microadenomas or empty sella may be found, but symptomatic corticotroph tumors have not been reported [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1,93\" class=\"abstract_t\">1,93</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Insulin resistance has been reported in patients with both classic [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/94\" class=\"abstract_t\">94</a>] and nonclassic [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/95\" class=\"abstract_t\">95</a>] 21OHD. Hyperandrogenism, glucocorticoid therapy, and epinephrine deficiency have all been implicated as possible risk factors for insulin resistance [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/14,94,95\" class=\"abstract_t\">14,94,95</a>]. Hyperleptinemia has also been reported [<a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/94,96\" class=\"abstract_t\">94,96</a>].</p><p/><p class=\"headingAnchor\" id=\"H3401764579\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-classic-and-nonclassic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Classic and nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=congenital-adrenal-hyperplasia-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Congenital adrenal hyperplasia (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">SUMMARY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Over 95 percent of cases of congenital adrenal hyperplasia (CAH) are due to 21-hydroxylase deficiency (21OHD) due to <em>CYP21A2</em> mutations. It is one of the most common known autosomal recessive disorders.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>It is not always possible to predict the phenotype of these patients from the specific mutation(s) of the <em>CYP21A2</em> gene, but there are general correlations between genotype and phenotype.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The utility of genotype in the management of the disease is unknown, and it is not routinely recommended. Genotyping is indicated if the diagnosis remains equivocal following hormonal evaluation or for genetic counseling.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Classic 21OHDresults in one of two clinical syndromes: a salt-losing form and the simple virilizing form. Girls with both forms present as neonates with atypical genitalia. Boys present as neonates with a salt-losing adrenal crisis (salt-losing form) (hyponatremia, hyperkalemia, and failure to thrive) or as toddlers with signs of puberty (simple virilizing form).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reproductive abnormalities are common in females and include structural abnormalities due to androgen excess in utero and anovulatory menstrual cycles.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In adult men, testicular masses (adrenal rests), Leydig cell dysfunction, and abnormal semen analyses may be seen.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonclassic or late-onset 21OHD may present as hirsutism and menstrual irregularity in young women, early pubarche or sexual precocity in school-age children, or there may be no symptoms. (See <a href=\"topic.htm?path=genetics-and-clinical-presentation-of-nonclassic-late-onset-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">&quot;Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis and treatment of classic 21OHD are reviewed separately. (See <a href=\"topic.htm?path=diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">&quot;Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;</a> and <a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-adults\" class=\"medical medical_review\">&quot;Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">&quot;Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/1\" class=\"nounderline abstract_t\">White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21:245.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/2\" class=\"nounderline abstract_t\">Pang SY, Wallace MA, Hofman L, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81:866.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/3\" class=\"nounderline abstract_t\">Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003; 349:776.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/4\" class=\"nounderline abstract_t\">Pang, S, Clark, A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993; 2:105.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/5\" class=\"nounderline abstract_t\">Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30:15.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/6\" class=\"nounderline abstract_t\">Lee HH, Kuo JM, Chao HT, et al. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J Clin Endocrinol Metab 2000; 85:597.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/7\" class=\"nounderline abstract_t\">New MI, White PC. Genetic disorders of steroid hormone synthesis and metabolism. Baillieres Clin Endocrinol Metab 1995; 9:525.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/8\" class=\"nounderline abstract_t\">Cutfield WS, Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 1995; 126:118.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/9\" class=\"nounderline abstract_t\">Pang S, Murphey W, Levine LS, et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982; 55:413.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/10\" class=\"nounderline abstract_t\">Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998; 101:583.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/11\" class=\"nounderline abstract_t\">Ferenczi A, Garami M, Kiss E, et al. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999; 84:2369.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/12\" class=\"nounderline abstract_t\">Tiitinen A, V&auml;lim&auml;ki M. Primary infertility in 45-year-old man with untreated 21-hydroxylase deficiency: successful outcome with glucocorticoid therapy. J Clin Endocrinol Metab 2002; 87:2442.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/13\" class=\"nounderline abstract_t\">Baumgartner-Parzer SM, Nowotny P, Heinze G, et al. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab 2005; 90:775.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/14\" class=\"nounderline abstract_t\">Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365:2125.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/15\" class=\"nounderline abstract_t\">Witchel SF, Lee PA, Suda-Hartman M, et al. Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1997; 82:2097.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/16\" class=\"nounderline abstract_t\">Carroll MC, Campbell RD, Porter RR. Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A 1985; 82:521.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/17\" class=\"nounderline abstract_t\">White PC, Grossberger D, Onufer BJ, et al. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A 1985; 82:1089.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/18\" class=\"nounderline abstract_t\">White PC, New MI, Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A 1986; 83:5111.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/19\" class=\"nounderline abstract_t\">Higashi Y, Yoshioka H, Yamane M, et al. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A 1986; 83:2841.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/20\" class=\"nounderline abstract_t\">Miller WL. Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 78:241.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/21\" class=\"nounderline abstract_t\">L'Allemand D, Tardy V, Gr&uuml;ters A, et al. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 2000; 85:4562.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/22\" class=\"nounderline abstract_t\">Miller WL. Gene conversions, deletions, and polymorphisms in congenital adrenal hyperplasia. Am J Hum Genet 1988; 42:4.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/23\" class=\"nounderline abstract_t\">Cooper DN, Ball EV, Krawczak M. The human gene mutation database. Nucleic Acids Res 1998; 26:285.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/24\" class=\"nounderline abstract_t\">Laji&#263; S, Clauin S, Robins T, et al. Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 2002; 87:2824.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/25\" class=\"nounderline abstract_t\">Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, et al. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 2003; 88:3852.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/26\" class=\"nounderline abstract_t\">Billerbeck AE, Mendonca BB, Pinto EM, et al. Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect. J Clin Endocrinol Metab 2002; 87:4314.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/27\" class=\"nounderline abstract_t\">Speiser PW, Dupont J, Zhu D, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992; 90:584.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/28\" class=\"nounderline abstract_t\">Wedell A, Thil&eacute;n A, Ritz&eacute;n EM, et al. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994; 78:1145.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/29\" class=\"nounderline abstract_t\">Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995; 80:2322.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/30\" class=\"nounderline abstract_t\">J&auml;&auml;skel&auml;inen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997; 82:3293.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/31\" class=\"nounderline abstract_t\">Ordo&ntilde;ez-S&aacute;nchez ML, Ram&iacute;rez-Jim&eacute;nez S, L&oacute;pez-Gutierrez AU, et al. Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations. Hum Genet 1998; 102:170.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/32\" class=\"nounderline abstract_t\">Nimkarn S, Cerame BI, Wei JQ, et al. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab 1999; 84:378.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/33\" class=\"nounderline abstract_t\">Koyama S, Toyoura T, Saisho S, et al. Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 2002; 87:2668.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/34\" class=\"nounderline abstract_t\">Finkielstain GP, Chen W, Mehta SP, et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2011; 96:E161.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/35\" class=\"nounderline abstract_t\">Higashi Y, Hiromasa T, Tanae A, et al. Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 1991; 109:638.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/36\" class=\"nounderline abstract_t\">Mornet E, Cr&eacute;t&eacute; P, Kuttenn F, et al. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet 1991; 48:79.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/37\" class=\"nounderline abstract_t\">Owerbach D, Ballard AL, Draznin MB. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction. J Clin Endocrinol Metab 1992; 74:553.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/38\" class=\"nounderline abstract_t\">Dardis A, Bergada I, Bergada C, et al. Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 1997; 10:55.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/39\" class=\"nounderline abstract_t\">Krone N, Braun A, Roscher AA, et al. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000; 85:1059.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/40\" class=\"nounderline abstract_t\">Deneux C, Tardy V, Dib A, et al. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2001; 86:207.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/41\" class=\"nounderline abstract_t\">Balsamo A, Cicognani A, Baldazzi L, et al. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency. J Clin Endocrinol Metab 2003; 88:5680.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/42\" class=\"nounderline abstract_t\">Grigorescu Sido A, Weber MM, Grigorescu Sido P, et al. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2005; 90:5769.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/43\" class=\"nounderline abstract_t\">Gutai JP, Kowarski AA, Migeon CJ. The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasia. J Pediatr 1977; 90:924.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/44\" class=\"nounderline abstract_t\">Charmandari E, Merke DP, Negro PJ, et al. Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. J Clin Endocrinol Metab 2004; 89:2228.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/45\" class=\"nounderline abstract_t\">Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:4133.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/46\" class=\"nounderline abstract_t\">Joint LWPES/ESPE CAH Working Group.. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 2002; 87:4048.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/47\" class=\"nounderline abstract_t\">Eugster EA, Dimeglio LA, Wright JC, et al. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 2001; 138:26.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/48\" class=\"nounderline abstract_t\">Berenbaum, SA, Snyder, E. Early hormonal influences on childhood sex-typed activity and playmate preferences: implications for the development of sexual orientation. Dev Psychol 1995; 31:31.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/49\" class=\"nounderline abstract_t\">Dittmann RW, Kappes MH, Kappes ME, et al. Congenital adrenal hyperplasia. I: Gender-related behavior and attitudes in female patients and sisters. Psychoneuroendocrinology 1990; 15:401.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/50\" class=\"nounderline abstract_t\">Berenbaum SA. Effects of early androgens on sex-typed activities and interests in adolescents with congenital adrenal hyperplasia. Horm Behav 1999; 35:102.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/51\" class=\"nounderline abstract_t\">Zucker KJ, Bradley SJ, Oliver G, et al. Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 1996; 30:300.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/52\" class=\"nounderline abstract_t\">Berenbaum SA, Resnick SM. Early androgen effects on aggression in children and adults with congenital adrenal hyperplasia. Psychoneuroendocrinology 1997; 22:505.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/53\" class=\"nounderline abstract_t\">Mathews GA, Fane BA, Conway GS, et al. Personality and congenital adrenal hyperplasia: possible effects of prenatal androgen exposure. Horm Behav 2009; 55:285.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/54\" class=\"nounderline abstract_t\">J&auml;&auml;skel&auml;inen, Voutilainen R. Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr 2000; 89:183.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/55\" class=\"nounderline abstract_t\">Berenbaum SA, Korman Bryk K, Duck SC, Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 2004; 144:741.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/56\" class=\"nounderline abstract_t\">Berenbaum SA. Cognitive function in congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30:173.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/57\" class=\"nounderline abstract_t\">Johannsen TH, Ripa CP, Reinisch JM, et al. Impaired cognitive function in women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91:1376.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/58\" class=\"nounderline abstract_t\">Nass R, Baker S. Androgen effects on cognition: congenital adrenal hyperplasia. Psychoneuroendocrinology 1991; 16:189.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/59\" class=\"nounderline abstract_t\">Helleday J, Bartfai A, Ritz&eacute;n EM, Forsman M. General intelligence and cognitive profile in women with congenital adrenal hyperplasia (CAH). Psychoneuroendocrinology 1994; 19:343.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/60\" class=\"nounderline abstract_t\">Kelso WM, Nicholls ME, Warne GL, Zacharin M. Cerebral lateralization and cognitive functioning in patients with congenital adrenal hyperplasia. Neuropsychology 2000; 14:370.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/61\" class=\"nounderline abstract_t\">Malouf MA, Migeon CJ, Carson KA, et al. Cognitive outcome in adult women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2006; 65:142.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/62\" class=\"nounderline abstract_t\">Mueller SC, Temple V, Oh E, et al. Early androgen exposure modulates spatial cognition in congenital adrenal hyperplasia (CAH). Psychoneuroendocrinology 2008; 33:973.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/63\" class=\"nounderline abstract_t\">Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316:178.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/64\" class=\"nounderline abstract_t\">Meyer-Bahlburg HF. What causes low rates of child-bearing in congenital adrenal hyperplasia? J Clin Endocrinol Metab 1999; 84:1844.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/65\" class=\"nounderline abstract_t\">Klingensmith GJ, Garcia SC, Jones HW, et al. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 1977; 90:996.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/66\" class=\"nounderline abstract_t\">Richards GE, Grumbach MM, Kaplan SL, Conte FA. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 47:1208.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/67\" class=\"nounderline abstract_t\">Stikkelbroeck NM, Hermus AR, Braat DD, Otten BJ. Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Obstet Gynecol Surv 2003; 58:275.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/68\" class=\"nounderline abstract_t\">Urban MD, Lee PA, Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 1978; 299:1392.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/69\" class=\"nounderline abstract_t\">Hagenfeldt K, Janson PO, Holmdahl G, et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23:1607.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/70\" class=\"nounderline abstract_t\">Nordenskj&ouml;ld A, Holmdahl G, Fris&eacute;n L, et al. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2008; 93:380.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/71\" class=\"nounderline abstract_t\">Lo JC, Schwitzgebel VM, Tyrrell JB, et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84:930.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/72\" class=\"nounderline abstract_t\">Stikkelbroeck NM, Hermus AR, Schouten D, et al. Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging. Eur Radiol 2004; 14:1802.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/73\" class=\"nounderline abstract_t\">Tiosano D, Vlodavsky E, Filmar S, et al. Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy. Horm Res Paediatr 2010; 74:223.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/74\" class=\"nounderline abstract_t\">Crocker MK, Barak S, Millo CM, et al. Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2012; 97:E2084.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/75\" class=\"nounderline abstract_t\">Lila AR, Malhotra G, Sarathi V, et al. Localization of remnant and ectopic adrenal tissues with cosyntropin-stimulated 18F-FDG-PET/CT in a patient with Nelson syndrome with persistent hypercortisolism. J Clin Endocrinol Metab 2010; 95:5172.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/76\" class=\"nounderline abstract_t\">Cabrera MS, Vogiatzi MG, New MI. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86:3070.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/77\" class=\"nounderline abstract_t\">Stikkelbroeck NM, Otten BJ, Pasic A, et al. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86:5721.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/78\" class=\"nounderline abstract_t\">Stikkelbroeck NM, Suliman HM, Otten BJ, et al. Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features. Eur Radiol 2003; 13:1597.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/79\" class=\"nounderline abstract_t\">Claahsen-van der Grinten HL, Otten BJ, Sweep FC, et al. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 2007; 92:3674.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/80\" class=\"nounderline abstract_t\">Vanzulli A, DelMaschio A, Paesano P, et al. Testicular masses in association with adrenogenital syndrome: US findings. Radiology 1992; 183:425.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/81\" class=\"nounderline abstract_t\">Avila NA, Shawker TS, Jones JV, et al. Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings. AJR Am J Roentgenol 1999; 172:1235.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/82\" class=\"nounderline abstract_t\">Claahsen-van der Grinten HL, Sweep FC, Blickman JG, et al. Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 2007; 157:339.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/83\" class=\"nounderline abstract_t\">Martinez-Aguayo A, Rocha A, Rojas N, et al. Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92:4583.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/84\" class=\"nounderline abstract_t\">Falhammar H, Nystr&ouml;m HF, Ekstr&ouml;m U, et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012; 166:441.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/85\" class=\"nounderline abstract_t\">Stikkelbroeck NM, Hermus AR, Suliman HM, et al. Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. J Pediatr Endocrinol Metab 2004; 17:645.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/86\" class=\"nounderline abstract_t\">Rutgers JL, Young RH, Scully RE. The testicular &quot;tumor&quot; of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am J Surg Pathol 1988; 12:503.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/87\" class=\"nounderline abstract_t\">J&oacute;dar-Gimeno E, Fern&aacute;ndez-Soto ML, Escobar-Jimenez F, et al. Association between congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency and bilateral testicular tumors: A report of two cases. Endocrinologist 1997; 7:65.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/88\" class=\"nounderline abstract_t\">Newfield RS, New MI. 21-hydroxylase deficiency. Ann N Y Acad Sci 1997; 816:219.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/89\" class=\"nounderline abstract_t\">Merke DP, Chrousos GP, Eisenhofer G, et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000; 343:1362.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/90\" class=\"nounderline abstract_t\">Weise M, Mehlinger SL, Drinkard B, et al. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab 2004; 89:591.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/91\" class=\"nounderline abstract_t\">Weise M, Drinkard B, Mehlinger SL, et al. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab 2004; 89:3679.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/92\" class=\"nounderline abstract_t\">Jaresch S, Kornely E, Kley HK, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992; 74:685.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/93\" class=\"nounderline abstract_t\">Charmandari E, Chrousos GP, Merke DP. Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2005; 18:97.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/94\" class=\"nounderline abstract_t\">Charmandari E, Weise M, Bornstein SR, et al. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87:2114.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/95\" class=\"nounderline abstract_t\">Speiser PW, Serrat J, New MI, Gertner JM. Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 75:1421.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-clinical-presentation-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency/abstract/96\" class=\"nounderline abstract_t\">Riepe FG, Krone N, Kr&uuml;ger SN, et al. Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes 2006; 114:105.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 149 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H19\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PREVALENCE</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">GENETICS</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Genotype versus phenotype</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">CLINICAL PRESENTATION</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">Infants/children</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">- Atypical genitalia</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Growth</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">Sexual behavior</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Cognitive function</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Female reproduction</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Male reproduction</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">- Testicular adrenal rests</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Infertility</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">Epinephrine deficiency</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Other findings</a></li></ul></li><li><a href=\"#H3401764579\" id=\"outline-link-H3401764579\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H102065984\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ENDO/149|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/81907\" class=\"graphic graphic_figure\">- 21 hydroxylase deficiency</a></li></ul></li><li><div id=\"ENDO/149|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/64870\" class=\"graphic graphic_picture\">- Clitoromegaly1</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=adrenal-steroid-biosynthesis\" class=\"medical medical_review\">Adrenal steroid biosynthesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-the-infant-with-atypical-genitalia-disorder-of-sex-development\" class=\"medical medical_review\">Evaluation of the infant with atypical genitalia (disorder of sex development)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetics-and-clinical-presentation-of-nonclassic-late-onset-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_review\">Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-the-infant-with-atypical-genitalia-disorder-of-sex-development\" class=\"medical medical_review\">Management of the infant with atypical genitalia (disorder of sex development)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-adrenal-hyperplasia-the-basics\" class=\"medical medical_basics\">Patient education: Congenital adrenal hyperplasia (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-classic-and-nonclassic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency\" class=\"medical medical_society_guidelines\">Society guideline links: Classic and nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-adults\" class=\"medical medical_review\">Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children\" class=\"medical medical_review\">Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uncommon-congenital-adrenal-hyperplasias\" class=\"medical medical_review\">Uncommon congenital adrenal hyperplasias</a></li></ul></div></div>","javascript":null}